Shenzhen Hanyu Pharmaceutical Co., Ltd.
Announcement on the First Grant of Restricted Shares to Incentive Recipients
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.
Key Information Highlights:
-
Restricted Share Grant Date: July 17, 2026;
-
Number of Restricted Shares Granted: 17.35 million shares;
-
Grant Price of Restricted Shares: ¥11.61 per share;
-
Equity Incentive Method: Class II Restricted Shares.
Shenzhen Hanyu Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") announces that the conditions for the first grant of restricted shares under the "2026 Restricted Share Incentive Plan (Draft)" (hereinafter referred to as the "Incentive Plan") have been met. Pursuant to the authorization of the Company's Third Extraordinary Shareholders' Meeting in 2026, the Sixth Board of Directors held its Sixteenth Meeting on July 17, 2026, and deliberated and approved the "Proposal on the First Grant of Restricted Shares to Incentive Recipients." The relevant matters are hereby described as follows.
I. Brief Overview of the Incentive Plan and Approval Procedures Completed
(I) Brief Overview of the Incentive Plan
-
Source of Shares for the Incentive Plan: A-shares repurchased from the secondary market and/or targeted additional issuance by the Company.
-
Number of Restricted Shares: The Incentive Plan intends to grant no more than 19.50 million restricted shares to incentive recipients, accounting for approximately 2.21% of the Company's total share capital as of the announcement date of the Incentive Plan draft. Among these, the initial grant is 17.35 million shares, accounting for approximately 1.96% of the Company's total share capital as of the announcement date of the Incentive Plan draft, and approximately 88.97% of the total equity to be granted; the reserved grant is 2.15 million shares, accounting for approximately 0.24% of the Company's total share capital as of the announcement date of the Incentive Plan draft, and approximately 11.03% of the total equity to be granted.
-
Grant Recipients: The incentive recipients of the Incentive Plan include directors, senior management personnel, management personnel of the Company (including its subsidiaries), and other core business (technical) backbones. It does not include independent directors of the Company, nor shareholders who individually or collectively hold more than 5% of the shares of the listed company or their actual controllers and their spouses, parents, and children. All incentive recipients have been verified by the Company's Remuneration and Assessment Committee.
-
Grant Price: The grant price for the initial and reserved grants of restricted shares under the Incentive Plan is ¥11.61 per share.
-
Validity Period of the Incentive Plan: The validity period of the Incentive Plan shall be from the date of the first grant of restricted shares to the date when all restricted shares granted to the incentive recipients are vested or become void due to expiration, with a maximum period of 60 months.
-
Vesting Arrangement of the Incentive Plan: Restricted shares may be vested according to the vesting arrangement of the Incentive Plan upon satisfaction of the corresponding vesting conditions. The vesting date must be a trading day and shall not fall within the following periods (if relevant regulations change, the changed regulations shall automatically apply):
(1) Within 15 days prior to the announcement of the Company's annual report, semi-annual report;
(2) Within 5 days prior to the announcement of the Company's quarterly report, performance forecast, or performance brief;
(3) From the date when a major event that may significantly affect the trading price of the Company's securities and their derivatives occurs or is under consideration, until the date of legal disclosure;
(4) Other periods stipulated by the China Securities Regulatory Commission and the stock exchange.